Patents by Inventor Florin Despa

Florin Despa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401428
    Abstract: The presently-disclosed subject matter generally relates to methods for treating a subject with Alzheimer's Disease, microhemorrhages, and neurological deficits. The presently-disclosed subject matter also relates to methods for treating a subject with Alzheimer's Disease, microhemorrhages, and neurological deficits with a composition that increases epoxyeicosatrienoic acids. The presently-disclosed subject matter further relates to a method of treating or preventing Alzheimer's Disease comprising administering an agent that increases vascular LRP1 expression.
    Type: Application
    Filed: October 1, 2020
    Publication date: December 22, 2022
    Inventor: Florin Despa
  • Patent number: 11105815
    Abstract: Methods for determining the presence of pathologic amylin in a subject with diabetes or pre-diabetes are provided herein. The method includes obtaining a skin sample from a subject and determining if there is pathologic amylin present in the skin sample.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: August 31, 2021
    Assignee: University of Kentucky Research Foundation
    Inventors: Larry B. Goldstein, Florin Despa
  • Publication number: 20200147026
    Abstract: The presently-disclosed subject matter generally relates to methods for detecting the presence of amylin in a patient's erythrocytes, determining the risk for the development of prediabetes, type-2 diabetes or comorbidities thereof, and methods of treating said diseases and risks.
    Type: Application
    Filed: November 14, 2019
    Publication date: May 14, 2020
    Inventor: Florin Despa
  • Publication number: 20190331696
    Abstract: The present invention relates to methods for determining the presence of pathologic amylin in a subject with diabetes or pre-diabetes. The method includes obtaining a skin sample from a subject and determining if there is pathologic amylin present in the skin sample.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 31, 2019
    Inventors: Larry B. Goldstein, Florin Despa
  • Patent number: 9572340
    Abstract: Compounds and methods for refolding of proteins in an aqueous solution. In particular, biocompatible multiblock copolymer surfactants such as poloxamers, meroxapols, poloxamines, or polyols are used to catalyze proper refolding without changing the protein composition, and restore the protein to its native conformation and native biological function. The methods can be practiced both in vivo and in vitro. The biocompatible multiblock copolymer surfactants can be used for renaturation of recombinantly expressed proteins, and for renaturation of proteins that are unfolded due to heat, irradiation, mechanical shearing, electrical shock, frostbite, chemical stress, and other abiotic or biotic stresses.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: February 21, 2017
    Assignee: UNIVERSITY OF CHICAGO
    Inventors: Raphael C Lee, Annie Kuo, Hanne Gissel Hyldkrog, Florin Despa, Devkumar Mustafi
  • Publication number: 20140342345
    Abstract: Compounds and methods for refolding of proteins in an aqueous solution. In particular, biocompatible multiblock copolymer surfactants such as poloxamers, meroxapols, poloxamines, or polyols are used to catalyze proper refolding without changing the protein composition, and restore the protein to its native conformation and native biological function. The methods can be practiced both in vivo and in vitro. The biocompatible multiblock copolymer surfactants can be used for renaturation of recombinantly expressed proteins, and for renaturation of proteins that are unfolded due to heat, irradiation, mechanical shearing, electrical shock, frostbite, chemical stress, and other abiotic or biotic stresses.
    Type: Application
    Filed: August 4, 2014
    Publication date: November 20, 2014
    Inventors: Raphael C. Lee, Annie Kuo, Hanne Gissel Hyldkrog, Florin Despa, Devkumar Mustafi
  • Patent number: 8815557
    Abstract: Compounds and methods for refolding of proteins in an aqueous solution. In particular, biocompatible multiblock copolymer surfactants such as poloxamers, meroxapols, poloxamines, or polyols are used to catalyze proper refolding without changing the protein composition, and restore the protein to its native conformation and native biological function. The methods can be practiced both in vivo and in vitro. The biocompatible multiblock copolymer surfactants can be used for renaturation of recombinantly expressed proteins, and for renaturation of proteins that are unfolded due to heat, irradiation, mechanical shearing, electrical shock, frostbite, chemical stress, and other abiotic or biotic stresses.
    Type: Grant
    Filed: July 10, 2006
    Date of Patent: August 26, 2014
    Assignee: University of Chicago
    Inventors: Raphael C. Lee, Annie Kuo, Hanne Gissel Hyldkrog, Florin Despa, Devkumar Mustafi
  • Publication number: 20130143804
    Abstract: Methods for predicting a propensity for heart or kidney failure in a diabetic or pre-diabetic individual by determining the amount and/or molecular weight of islet amyloid polypeptide present in a sample from the individual are provided.
    Type: Application
    Filed: June 7, 2011
    Publication date: June 6, 2013
    Applicants: Trustees of the University of Pennsylvania, The Regents of the University of California
    Inventors: Florin Despa, Sanda Despa, Donald M. Bers, Kenneth B. Margulies
  • Publication number: 20070031955
    Abstract: Compounds and methods for refolding of proteins in an aqueous solution. In particular, biocompatible multiblock copolymer surfactants such as poloxamers, meroxapols, poloxamines, or polyols are used to catalyze proper refolding without changing the protein composition, and restore the protein to its native conformation and native biological function. The methods can be practiced both in vivo and in vitro. The biocompatible multiblock copolymer surfactants can be used for renaturation of recombinantly expressed proteins, and for renaturation of proteins that are unfolded due to heat, irradiation, mechanical shearing, electrical shock, frostbite, chemical stress, and other abiotic or biotic stresses.
    Type: Application
    Filed: July 10, 2006
    Publication date: February 8, 2007
    Inventors: Raphael Lee, Annie Kuo, Hanne Hyldkrog, Florin Despa, Devkumar Mustafi